Cargando…
An explorative analysis of ERCC1-19q13 copy number aberrations in a chemonaive stage III colorectal cancer cohort
BACKGROUND: Platinum-based chemotherapy has long been used in the treatment of a variety of cancers and functions by inducing DNA damage. ERCC1 and ERCC4 are involved in the removal of this damage and have previously been implicated in resistance to platinum compounds. The aim of the current investi...
Autores principales: | Smith, David Hersi, Christensen, Ib Jarle, Jensen, Niels Frank, Markussen, Bo, Müller, Sven, Nielsen, Hans Jørgen, Brünner, Nils, Nielsen, Kirsten Vang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015772/ https://www.ncbi.nlm.nih.gov/pubmed/24144331 http://dx.doi.org/10.1186/1471-2407-13-489 |
Ejemplares similares
-
Mechanisms of Topoisomerase I (TOP1) Gene Copy Number Increase in a Stage III Colorectal Cancer Patient Cohort
por: Smith, David Hersi, et al.
Publicado: (2013) -
Measuring ERCC1 protein expression in cancer specimens: Validation of a novel antibody
por: Smith, David Hersi, et al.
Publicado: (2014) -
Histopathological Growth Pattern, Proteolysis and Angiogenesis in Chemonaive Patients Resected for Multiple Colorectal Liver Metastases
por: Eefsen, Rikke Løvendahl, et al.
Publicado: (2012) -
Data fusion in metabolomic cancer diagnostics
por: Bro, Rasmus, et al.
Publicado: (2012) -
Early Detection and Recurrence of Colorectal Adenomas by Combination of Eight Cancer-Associated Biomarkers in Plasma
por: Rasmussen, Louise, et al.
Publicado: (2020)